Impairment of Circulating Follicular Helper T Cells in HIV-Positive Individuals Who Are Negative for Hepatitis B Surface Antibody Despite Vaccination - Summary - MDSpire

Impairment of Circulating Follicular Helper T Cells in HIV-Positive Individuals Who Are Negative for Hepatitis B Surface Antibody Despite Vaccination

  • By

  • Ayako Sedohara

  • Yoshiaki Kanno

  • Keiko Arai

  • Kotaro Arizono

  • Michiko Koga

  • Fumio Nakahara

  • Makoto Saito

  • Eisuke Adachi

  • Hiroshi Yotsuyanagi

  • March 11, 2026

  • 0 min

Share

Objective:

To investigate the frequency and function of circulating T follicular helper (cTfh) cells in HIV-positive individuals who are negative for hepatitis B surface antibody (HBsAb–) after HBV vaccination, highlighting the importance of understanding immune responses in this population.

Key Findings:
  • Three out of 26 PWH tested HBsAb– after receiving three doses of the HBV vaccine, indicating a significant failure in antibody production.
  • HBsAb– PWH exhibited lower frequencies of cTfh cells compared to HBsAb+ PWH and non-HIV controls, suggesting a potential link to impaired humoral immunity.
  • Persistent HIV infection negatively impacts the function of cTfh cells, which may contribute to the observed impaired humoral immunity.
Interpretation:

The study suggests that HIV infection may impair the function of cTfh cells, potentially explaining the lower antibody response to HBV vaccination in HIV-positive individuals, necessitating further investigation into immune restoration strategies.

Limitations:
  • Small sample size of PWH and non-HIV controls, which may limit the generalizability of the findings.
  • Short follow-up period for monitoring antibody titers post-vaccination, potentially affecting the assessment of long-term vaccine efficacy.
Conclusion:

HIV-positive individuals who do not produce antibodies after HBV vaccination show impaired cTfh cell function, indicating a need for further research into enhancing vaccine responses in this population, particularly focusing on immune modulation strategies.

Original Source(s)

Related Content